Vimta Labs Limited

NSE VIMTALABS.NS

Vimta Labs Limited Operating Income Margin for the year ending March 31, 2024: -4.12%

Vimta Labs Limited Operating Income Margin is -4.12% for the year ending March 31, 2024, a -119.38% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Vimta Labs Limited Operating Income Margin for the year ending March 31, 2023 was 21.26%, a 2.99% change year over year.
Vimta Labs Limited Operating Income Margin for the year ending March 31, 2022 was 20.64%, a 19.33% change year over year.
Vimta Labs Limited Operating Income Margin for the year ending March 31, 2021 was 17.30%, a 180.37% change year over year.
Vimta Labs Limited Operating Income Margin for the year ending March 31, 2020 was 6.17%, a -71.28% change year over year.

Key data

Date	Operating Income Margin	EBT Margin	Net Income Margin	EBITDA Margin

NSE: VIMTALABS.NS

Vimta Labs Limited

CEO	Dr. Sivalinga Prasad Vasireddi
IPO Date	Dec. 15, 2005
Location	India
Headquarters	Plot Nos. 141/2 & 142, IDA, Phase II
Employees	1,428
Sector	Healthcare
Industries Biotechnology Clinical Trials Medical Instruments Personal Care Pharmaceuticals Pollution Treatment Research & Consulting Vaccines

Description

Vimta Labs Limited provides contract research and testing services in India and internationally. It offers laboratory, food and water testing and analysis, preclinical and clinical research, biological molecule structural and functional analysis, environmental assessment, and clinical reference laboratory services. The company serves pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and various other industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.

Key trends

Past 5 years